Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.
about
APS and the brain.[Antiphospholipid antibody syndrome].Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography.Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview.Echocardiography in the evaluation of cardiac sources of emboli: the role of transthoracic echocardiography.Simultaneous liver resection and double cardiac valve replacement. A case report.The antiphospholipid syndrome: a syndrome in evolutionSevere valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.Myocardial infarction with normal coronary arteries in a patient with primary antiphospholipid syndrome--case report and literature review.Long-term cardiac changes in patients with systemic lupus erythematosusDouble-valve Libman-Sacks endocarditis causing ventricular fibrillation cardiac arrest.Antiphospholipid antibodies and cardiovascular disease.Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa.Cardiac involvement in the antiphospholipid syndrome.Cardiac manifestations of rheumatological conditions: a narrative reviewM mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndromeTriple Valvulopathy and Jaccoud's Arthropathy: A Case Report and Literature Review.Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review.Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.Stroke prevention in patients with antiphospholipid antibodies.Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis.Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.Echocardiographic abnormalities in a cohort of Chinese patients with systemic lupus erythematosus--a retrospective analysis of eighty-five cases.Cardiac involvement in patients with systemic lupus erythematosus and correlation of valvular lesions with anti-Ro/SS-A and anti-La/SS-B antibody levels.Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.Heart failure in systemic lupus erythematosus treated by cardiac resynchronization: a case report.Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise.Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosusRecurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies
P2860
Q33196667-E6AE3DF8-17B0-4648-9E3A-B320716B75B8Q33328463-643A4B38-CB0C-4073-A71A-6A8A827E6A7AQ33334045-9226BCBB-7C92-4920-BCEB-E393083FB4F0Q33499192-9E748BF1-0472-446F-A33B-122BCA7C8A7EQ33559372-7B1A1C31-E50D-45DD-B50D-DCFF6CB1AA79Q33561599-1DE05800-A15E-490A-B768-52B7AD131450Q33567393-79096605-7CB6-4E8A-B17D-9DFBE32CFD90Q33987561-48AFFD73-53BE-4A0D-996E-959C09EF9B29Q34444517-81AA8078-78F8-4DEC-AA96-CDE88967CC95Q34699205-87657394-B36C-495F-9A51-5554DD9C7DEFQ35039572-A06BB415-8018-494A-A2C2-772AFEA06234Q35356556-F45A8D80-810F-4442-A5DC-FB7314874FFDQ35549777-356521D6-E4FD-4DB0-BCF0-B43262AE8DE9Q36029552-96F637E0-C64A-4369-862A-9E81AB1C146DQ36283448-C05A14EC-2491-4AD8-8EB2-B830275C470AQ36355415-C7C27D32-F7E1-45FC-AC91-2B9E8DA814FCQ36824941-D224109B-F700-4BEB-A4FE-7BFDFB570645Q37084271-72974B4A-445F-42F4-9622-F57A601A9EC8Q37826101-42CFD575-802A-4E3B-9F2C-3BBC4C1D984DQ38237868-35DC665D-7B06-4845-86EF-B06658E7678AQ40558537-301548B9-2203-4A01-90AE-AD25ACB983FCQ40583128-848D595B-7D83-4CAF-97A0-A9A2679E6CCFQ44244036-A0E69401-0846-4CED-B5AF-31F202C2F60AQ46031084-A086A4D9-C40F-4A6B-8F94-9ECEA9099A2DQ46302052-D0A22AB6-278F-48E8-97C0-D46EF840B6D3Q51315360-4B7558D3-1007-46A7-9882-2BD02087C50CQ51753640-B457822D-CF33-429F-9C8D-4623994C4BA2Q53159273-702854E9-CFFC-4A08-8ED4-E1D8C12D5EB3Q53241480-E929635E-2E07-4E36-95B7-6ED2C824628CQ57216969-67B3AA42-6AD5-40E2-AB71-5DE4535F559FQ58861357-D23E8718-4840-4CDA-8318-B9723650892F
P2860
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@en
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@nl
type
label
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@en
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@nl
prefLabel
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@en
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@nl
P2093
P356
P1433
P1476
Cardiac abnormalities in syste ...... ed anticardiolipin antibodies.
@en
P2093
Nihoyannopoulos P
P304
P356
10.1161/01.CIR.82.2.369
P407
P50
P577
1990-08-01T00:00:00Z